載入...
A Comparison of Response Patterns for Progression-Free Survival and Overall Survival Following Treatment for Cancer With PD-1 Inhibitors: A Meta-analysis of Correlation and Differences in Effect Sizes
IMPORTANCE: Based on efficacy results from pivotal randomized clinical trials, PD-1 (programmed cell death 1) inhibitors, such as nivolumab and pembrolizumab, have been approved to treat various cancers. Response patterns with varying effects on progression-free survival (PFS) and overall survival (...
Na minha lista:
| 發表在: | JAMA Netw Open |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Medical Association
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6324401/ https://ncbi.nlm.nih.gov/pubmed/30646078 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamanetworkopen.2018.0416 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|